Skip to main content
Fig. 4 | Molecular Medicine

Fig. 4

From: The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD)

Fig. 4

The β3-AR agonist BRL37344 modulated key proteins and genes for FFA β-oxidation. a Quantitative analysis of the protein levels of PPAR-α and PPAR-γ in the livers of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups (each group, n = 8). b Representative western blot bands of the PPAR-α and PPAR-γ proteins in the livers of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups. c Quantitative analysis of the expression of the PPAR-α and PPAR-γ genes in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups (each group, n = 8). d Quantitative analysis of the protein levels of mCPT-1 and CD36 in the livers of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups (each group, n = 8). e Representative western blot bands of the mCPT-1 and CD36 proteins in the livers of rats in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups. f Quantitative analysis of the expression of the mCPT-1 and CD36 genes in the control, HFD, HFD + β3-AGO and HFD + β3-ANT groups (each group, n = 8). *P < 0.05 vs the control group, #P < 0.05 vs the HFD group

Back to article page

Molecular Medicine

ISSN: 1528-3658